SOM3355 (Bevantolol hydrochloride), discovered through SOM Biotech’s proprietary artificial intelligence-based computational technology SOMAIPRO, is an alternative VMAT2 inhibitor that could be repositioned to treat chorea in HD and potentially eliminate the severe side effects of Xenazine. The gene discussed is SLC18A2; the disease is Huntington disease.